<?xml version="1.0" encoding="UTF-8"?>
<Label drug="medrol" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

    Fluid and Electrolyte Disturbances  



 *  Sodium retention 
 *  Congestive heart failure in susceptible patients 
 *  Hypertension 
 *  Fluid retention 
 *  Potassium loss 
 *  Hypokalemic alkalosis 
      Musculoskeletal  
 

 *  Muscle weakness 
 *  Loss of muscle mass 
 *  Steroid myopathy 
 *  Osteoporosis 
 *  Tendon rupture, particularly of the Achilles tendon 
 *  Vertebral compression fractures 
 *  Aseptic necrosis of femoral and humeral heads 
 *  Pathologic fracture of long bones 
      Gastrointestinal  
 

 *  Peptic ulcer with possible perforation and hemorrhage 
 *  Pancreatitis 
 *  Abdominal distention 
 *  Ulcerative esophagitis 
    Increases in alanine transaminase (ALT, SGPT), aspartate transaminase (AST, SGOT), and alkaline phosphatase have been observed following corticosteroid treatment. These changes are usually small, not associated with any clinical syndrome and are reversible upon discontinuation.
 

   Dermatologic  



 *  Impaired wound healing 
 *  Petechiae and ecchymoses 
 *  May suppress reactions to skin tests 
 *  Thin fragile skin 
 *  Facial erythema 
 *  Increased sweating 
      Neurological  
 

 *  Increased intracranial pressure with papilledema (pseudo-tumor cerebri) usually after treatment 
 *  Convulsions 
 *  Vertigo 
 *  Headache 
      Endocrine  
 

 *  Development of Cushingoid state 
 *  Suppression of growth in children 
 *  Secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery or illness 
 *  Menstrual irregularities 
 *  Decreased carbohydrate tolerance 
 *  Manifestations of latent diabetes mellitus 
 *  Increased requirements of insulin or oral hypoglycemic agents in diabetics 
      Ophthalmic  
 

 *  Posterior subcapsular cataracts 
 *  Increased intraocular pressure 
 *  Glaucoma 
 *  Exophthalmos 
      Metabolic  
 

 *  Negative nitrogen balance due to protein catabolism 
    The following additional reactions have been reported following oral as well as parenteral therapy: Urticaria and other allergic, anaphylactic or hypersensitivity reactions.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
